en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
3/2021
vol. 123
 
Share:
Share:
more
 
 
abstract:
Review paper

Mycotic corneal ulcers caused by Fusarium spp.- available therapeutic options

Ewelina Trojacka
1
,
Justyna Izdebska
1, 2
,
Marta Wroblewska
3, 4
,
Beata Sulik-Tyszka
3, 4
,
Karolina Ciepiaszuk
1, 2
,
Jacek P. Szaflik
1

1.
Independent Public Clinical Ophthalmology Hospital in Warsaw, Poland
2.
Chair and Department of Ophthalmology, II Faculty of Medicine, Medical University of Warsaw, Poland
3.
Department of Microbiology of the Central Clinical Hospital, University Clinical Center of the Medical University of Warsaw, Poland
4.
Department of Dental Microbiology, Medical University of Warsaw, Poland
KLINIKA OCZNA 2021, 123, 3: 108–113
Online publish date: 2021/10/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Fungal corneal ulcers caused by Fusarium spp. are known as sight threatening infection with bad course.

Fungus properties, diagnostic difficulties and limited therapeutic ways result in poor outcomes.

Three of antimycotic drugs are effective against Fusarium spp.: natamycin, amphotericin B and voriconazole. Natamycin is the only drug approved by FDA (Food and Drug Administration) for treatment of corneal ulcers caused by Fusarium spp.

Fungistatic work and limited ocular penetration of antimycotic drugs lead to therapeutic keratoplasty in cases with extremely bad course. Patient with recurrent infections and very advanced inflammation, require enucleation.
keywords:

corneal ulcer, Fusarium spp, natamycin, voriconazole, therapeutic penetrating keratoplasty

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.